Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Oncternal Therapeutics Inc. buy DrMabuse

Start price
€5.95
22.02.21 / 0%
Target price
-
2022-02-22
Performance (%)
-17.65%
Price
€4.90
03.03.21
This prediction is currently active. The prediction for Oncternal Therapeutics Inc. disappoints with a performance of -17.65%. This prediction currently runs until 2022-02-22. The prediction end date can be changed by DrMabuse at any time. This prediction was marked as speculative and is excluded from DrMabuse's performance statistics.

According to DrMabuse what are the pros and cons of Oncternal Therapeutics Inc. for the foreseeable future?

Pros
Cons
Risky Investment

Comments by DrMabuse for this prediction

In the thread Oncternal Therapeutics Inc. diskutieren

Buy Oncternal Therapeutics Inc.